Christina Fotopoulou
Christina Fotopoulou is an expert in Gynecology at Imperial College Healthcare NHS Trust (United Kingdom). As of October 2026, ScienceLeadR ranks Christina Fotopoulou in the top 1% of experts worldwide for Ovarian Neoplasms, Adnexal Diseases and Gonadal Disorders. Christina Fotopoulou has authored 428 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 4 of them ongoing. SLR score: 1,404 (community average: 125). How the SLR is computed.
LeadR Profile
Gynecology
Subspecialties: Oncology - Obstetrics - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 428
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Fertility counseling and preservation considerations in patients with gynecologic and non-gynecologic BRCA and Lynch-associated malignancies. PMID 42852624 — fertility, fertility preservation, neoplasms, obstetrics, therapeutics, counseling, mutation | Int J Gynaecol Obstet | 2026 | 0 |
| Global implementation of hereditary cancer care in gynecologic oncology: Development and evaluation of the Hereditary Cancer Care Implementation Index. PMID 42817777 — research design, genetic testing, preventive medicine, neoplasms, income, obstetrics, benchmarking, implementation science, workforce | Int J Gynaecol Obstet | 2026 | 0 |
| FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions. PMID 42677467 — obstetrics, squamous intraepithelial lesions, uterine cervical dysplasia, research, therapeutics, alphapapillomavirus, wounds and injuries, papillomavirus infections, infections, human papillomavirus viruses | Int J Gynaecol Obstet | 2026 | 0 |
| Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK. PMID 42673272 — ultrasonography, obstetrics, ultrasonography, prenatal, gynecology | Ultrasound Obstet Gynecol | 2026 | 0 |
| Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)". PMID 42660770 — confidence intervals, cytoreduction surgical procedures, progression-free survival, ovary, genital neoplasms, female, neoplasms, multiple chronic conditions, ribose, bevacizumab, drug therapy, adenosine, maintenance, ovarian neoplasms, adenosine diphosphate, research, therapeutics, chemotherapy | Int J Gynecol Cancer | 2026 | 1 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Ovarian Cancer Radiomics Approach in CT Led Evaluation NCT06817174 — ovary, neoplasms, biomarkers, ovarian neoplasms, therapeutics, carcinoma, ovarian epithelial, prognosis, carcinoma | N/A | Recruiting | 2025 |
| A Study of Radspherin in Patients With Primary Advanced Epithelial Cancer With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery NCT06504147 — recombination, genetic, homologous recombination, suspensions, ovary, neoplasms, drug therapy, neoplasm metastasis, ovarian neoplasms, calcium, peritoneal neoplasms, therapeutics, fallopian tubes, chemotherapy | Phase 2 | Recruiting | 2024 |
| Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer NCT06416748 — margins of excision, minimally invasive surgical procedures, lymph nodes, conization, hysterectomy, uterine cervical neoplasms, neoplasms, sentinel lymph node, biopsy, laparoscopy, algorithms, lymph, therapeutics, sentinel lymph node biopsy, cervix uteri | N/A | Recruiting | 2024 |
| PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map